Sibley School of Mechanical Engineering, Cornell University, Ithaca, NY, United States.
Meinig School of Biomedical Engineering Cornell University, Ithaca, NY, United States.
Acta Biomater. 2021 Sep 1;131:276-285. doi: 10.1016/j.actbio.2021.07.003. Epub 2021 Jul 8.
Multiple human tissue engineered cartilage constructs are showing promise in advanced clinical trials but identifying important measures of manufacturing reproducibility remains a challenge. FDA guidance suggests measuring multiple mechanical properties prior to implantation, because these properties could affect the long term success of the implant. Additionally, these engineered cartilage mechanics could be sensitive to the autologous chondrocyte source, an inherently irregular manufacturing starting material. If any mechanical properties are sensitive to changes in the autologous chondrocyte source, these properties may need to be measured prior to implantation to ensure manufacturing reproducibility and quality. Therefore, this study identified variability in the compressive, friction, and shear properties of a human tissue engineered cartilage constructs due to the chondrocyte source. Over 200 constructs were created from 7 different chondrocyte sources and tested using 3 distinct mechanical experiments. Under confined compression, the compressive properties (aggregate modulus and hydraulic permeability) varied by orders of magnitude due to the chondrocyte source. The friction coefficient changed by a factor of 5 due to the chondrocyte source and high intrapatient variability was noted. In contrast, the shear modulus was not affected by changes in the chondrocyte source. Finally, measurements on the local compressive and shear mechanics revealed variability in the depth dependent strain fields based on chondrocyte source. Since the chondrocyte source causes large amounts of variability in the compression and local mechanical properties of engineered cartilage, these mechanical properties may be important measures of manufacturing reproducibility. STATEMENT OF SIGNIFICANCE: Although the FDA recommends measuring mechanical properties of human tissue engineered cartilage constructs during manufacturing, the effect of manufacturing variability on construct mechanics is unknown. As one of the first studies to measure multiple mechanical properties on hundreds of human tissue engineered cartilage constructs, we found the compressive properties are most sensitive to changes in the autologous chondrocyte source, an inherently irregular manufacturing variable. This sensitivity to the autologous chondrocyte source reveals the compressive properties should be measured prior to implantation to assess manufacturing reproducibility.
多种人体组织工程软骨构建体在先进的临床试验中显示出前景,但确定制造可重复性的重要衡量标准仍然是一个挑战。FDA 指南建议在植入前测量多种机械性能,因为这些性能可能会影响植入物的长期成功。此外,这些工程软骨力学性能可能对自体软骨细胞来源敏感,而自体软骨细胞来源是一种固有的不规则制造起始材料。如果任何机械性能对自体软骨细胞来源的变化敏感,则在植入前需要测量这些性能,以确保制造可重复性和质量。因此,本研究确定了由于软骨细胞来源,人体组织工程软骨构建体的压缩、摩擦和剪切性能的可变性。使用 3 种不同的机械实验,从 7 种不同的软骨细胞来源中创建了超过 200 个构建体并进行了测试。在受限压缩下,由于软骨细胞来源,压缩性能(聚合模量和液压渗透性)的变化幅度可达数量级。摩擦系数因软骨细胞来源而变化了 5 倍,并且注意到了高个体内变异性。相比之下,剪切模量不受软骨细胞来源变化的影响。最后,对局部压缩和剪切力学的测量揭示了基于软骨细胞来源的深度相关应变场的可变性。由于软骨细胞来源会导致工程软骨的压缩和局部力学性能产生大量变化,因此这些力学性能可能是制造可重复性的重要衡量标准。
尽管 FDA 建议在制造过程中测量人体组织工程软骨构建体的机械性能,但制造变异性对构建体力学的影响尚不清楚。作为首批测量数百个人体组织工程软骨构建体的多种机械性能的研究之一,我们发现压缩性能对自体软骨细胞来源的变化最敏感,而自体软骨细胞来源是一种固有的不规则制造变量。对自体软骨细胞来源的这种敏感性表明,在植入前应测量压缩性能,以评估制造可重复性。